Thryv Therapeutics Inc. Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNewsfile Corp • 04/04/24
Thryv Grows SaaS Revenue 25% in Fourth Quarter 2023, Exceeds Full Year SaaS GuidanceBusiness Wire • 02/22/24
Thryv To Release Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 22Business Wire • 01/30/24
Small Business Owners are Bullish on Their Futures, Thryv Small Business Index ShowsBusiness Wire • 12/13/23
Thryv Exceeds Third Quarter 2023 SaaS Guidance, Raises Full-Year SaaS OutlookBusiness Wire • 11/02/23
Thryv Receives Numerous Accolades in G2 2023 Fall Report, including Momentum Leader and Leader for Small Business and OverallBusiness Wire • 09/19/23
Thryv Recognized Among “Best Places to Work in Dallas” list by Dallas Business Journal and Employer of Choice in The Australian Business AwardsBusiness Wire • 09/14/23
Thryv Receives Industry Accolades for Its Innovative SaaS Small Business PlatformBusiness Wire • 08/31/23
Thryv Holdings, Inc. (THRY) Q2 Earnings and Revenues Lag EstimatesZacks Investment Research • 08/03/23
Thryv Enhances its Market-Leading, SaaS-Based Business Management Platform and Sees Increased Customer EngagementBusiness Wire • 08/03/23
Thryv Grows SaaS Profitability in the Second Quarter, Raises Full-Year 2023 GuidanceBusiness Wire • 08/03/23